Taken together, we observed the LCOR-RUNX1-PLCL1 cascade accounts for multiple anti-tumor activities in ccRCC cells, upholding its candidacy as a novel diagnostic and therapeutic target. The gene discussed is RUNX1; the disease is neoplasm.